Skip to content
Biodatica
Start free

CORIELL INSTITUTE FOR MEDICAL RESEARCH

CAMDEN, NJ

OncologyGrant-only
Compare Sign in to watch

What changed

Study registered, no phase assigned: Antenatal vs Postnatal Transport Team Positioning in Extremely Preterm Outborn Infants

7w agoTrial registeredMay 28, 2026Source filing (opens the source filing in a new tab)

Momentum

68no change

Momentum 68 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

12,847 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    Study registered

    Jun 1, 2026

    Prematurity Complications, Neurodevelopment Outcome, Prematurity · NOT_YET_RECRUITING · sponsor: Assistance Publique - Hôpitaux de Paris · Antenatal vs Postnatal Transport Team Positioning in Extremely Preterm Outborn Infants

    ClinicalTrials.gov · NCT07580859 (opens the source filing in a new tab)

  2. Grant

    P50 · $249k · non-dilutive

    Aug 16, 2021

    CORIELL INSTITUTE FOR MEDICAL RESEARCH · PI ISSA, JEAN-PIERRE J. · NCI · award ends Jun 30, 2027 · Genomics Core

    NIH RePORTER · NIH RePORTER 11140517 (opens the source filing in a new tab)

  3. Grant

    P50 · $89k · non-dilutive

    Aug 16, 2021

    CORIELL INSTITUTE FOR MEDICAL RESEARCH · PI ISSA, JEAN-PIERRE J. · NCI · award ends Jun 30, 2027 · Career Enhancement Program

    NIH RePORTER · NIH RePORTER 11140527 (opens the source filing in a new tab)

  4. Grant

    P50 · $89k · non-dilutive

    Aug 16, 2021

    CORIELL INSTITUTE FOR MEDICAL RESEARCH · PI ISSA, JEAN-PIERRE J. · NCI · award ends Jun 30, 2027 · Developmental Research Program

    NIH RePORTER · NIH RePORTER 11140526 (opens the source filing in a new tab)

  5. Grant

    P50 · $430k · non-dilutive

    Aug 16, 2021

    CORIELL INSTITUTE FOR MEDICAL RESEARCH · PI ISSA, JEAN-PIERRE J. · NCI · award ends Jun 30, 2027 · Admin Core

    NIH RePORTER · NIH RePORTER 11140515 (opens the source filing in a new tab)

  6. Grant

    P50 · $2.5M · non-dilutive

    Aug 16, 2021

    CORIELL INSTITUTE FOR MEDICAL RESEARCH · PI ISSA, JEAN-PIERRE J. · NCI · award ends Jun 30, 2027 · Epigenetic Therapies - New Approaches

    NIH RePORTER · NIH RePORTER 11140513 (opens the source filing in a new tab)

  7. Grant

    T32 · $495k · non-dilutive

    Jul 5, 2021

    VAN ANDEL RESEARCH INSTITUTE · PI JONES, PETER A · NCI · award ends Jul 8, 2026 · Cancer Epigenetics Training (CET) Program

    NIH RePORTER · NIH RePORTER 11118804 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources